Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity? Response from the MIABE group (2012)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/nrd3503-c2
Publication URI: http://dx.doi.org/10.1038/nrd3503-c2
Type: Journal Article/Review
Parent Publication: Nature Reviews Drug Discovery
Issue: 9